GLP1R and medullary thyroid gland carcinoma: Preclinical studies suggest that GLP‐1 receptor activation promotes C‐cell proliferation and increases the risk of thyroid cancer, including medullary thyroid carcinoma (MTC), in rodents, likely due to higher GLP‐1 receptor expression in thyroid cells [14, 15].